← Eichor
Condition: Diabetic Macular Edema Dme Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Diabetic Macular Edema Dme

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase 2 Trial of RGX-314 in Adults With Center Involved - Diabetic Macular Edema (CI - DME)
Phase 2 · 1 location(s) · Sierra Eye Associates · NCT06942520Biomarkers in Diabetic Retinopathy Treated With Faricimab vs Biosimilar Ranibizumab
NA · 1 location(s) · Osijek University Hospital · NCT07520045High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy
Phase 4 · 1 location(s) · Retina Consultants of Orange County · NCT06662994CAPRI: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · 68 location(s) · EyePoint Pharmaceuticals, Inc. · NCT07449923Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Phase 1 · 5 location(s) · Ocugen · NCT05802329Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant
NA · 2 location(s) · Vastra Gotaland Region · NCT06984822Investigating the Metabolic and Lipidomic Profiles That Are Associated With Varying Grades of Diabetic Maculopathy and R
Phase N/A · 1 location(s) · Hywel Dda Health Board · NCT06914778COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME
Phase 3 · 70 location(s) · EyePoint Pharmaceuticals, Inc. · NCT07449936Gene Therapy for DME
Phase 1/Phase 2 · 1 location(s) · Frontera Therapeutics · NCT06492876Surabgene Lomparvovec Administered in the Suprachoroidal Space in Adult Participants With Diabetic Retinopathy Without C
Phase 2/Phase 3 · 15 location(s) · AbbVie · NCT07592273Safety and Efficacy Evaluation of LX111 Gene Therapy in DME Patients
EARLY_Phase 1 · 2 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT07362927Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Diabetic Macular Edema
Phase 3 · 50 location(s) · Bio-Thera Solutions · NCT07515079A Phase 2 Study to Evaluate the Efficacy and Safety of ENN0403 in Subjects with DME
Phase 2 · 1 location(s) · EnnovaBio · NCT06708260A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With D
Phase 1 · 10 location(s) · Genentech, Inc. · NCT07425522Kamuvudine-9 (K9) in Diabetic Macular Edema
Phase 1/Phase 2 · 1 location(s) · Dr. Bryan Strelow · NCT07458061Impact of Intravitreal Faricimab on Renal Function in Diabetic Patients
NA · 2 location(s) · University Hospital, Alexandroupolis · NCT06929507MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema
Phase 1 · 3 location(s) · Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. · NCT04187443DATA-INSIGHT is a Project That Looks at Health Data in Germany to Find Out How Many Patients Suffer From Eye Disease. Th
Phase N/A · 1 location(s) · Bayer · NCT07308639
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.